Downregulation of monocytic differentiation via modulation of CD147 by 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors

Inhibition of EMMPRIN and MMP-9 Expression by Epigallocatechin-3-Gallate through 67-kDa Laminin Receptor in PMA-Induced Macrophages

(2016) Qi-Ming Wang et al.   CELLULAR PHYSIOLOGY AND BIOCHEMISTRY

Evaluating Soluble EMMPRIN as a Marker of Disease Activity in Multiple Sclerosis: Studies of Serum and Cerebrospinal Fluid

(2016) Deepak K. Kaushik et al.   PLoS One

Functional Relevance of Protein Glycosylation to the Pro-Inflammatory Effects of Extracellular Matrix Metalloproteinase Inducer (EMMPRIN) on Monocytes/Macrophages

(2015) Heng Ge et al.   PLoS One

Impact of Matrix Metalloproteinases on Atherosclerosis

(2014) Juntang Lin et al.   CURRENT DRUG TARGETS

Macrophage phenotypes in atherosclerosis

(2014) Sophie Colin et al.   IMMUNOLOGICAL REVIEWS

Inhibiting effects of Leflunomide metabolite on overexpression of CD147, MMP-2 and MMP-9 in PMA differentiated THP-1 cells

(2011) Jian-lin Huang et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Atorvastatin Combined To Interferon to Verify the Efficacy (ACTIVE) in relapsing— remitting active multiple sclerosis patients: a longitudinal controlled trial of combination therapy

(2010) Roberta Lanzillo et al.   Multiple Sclerosis Journal

Expression of CD147 on phorbol-12-myris-tate-13-acetate (PMA)-treated U937 cells differentiating into foam cells

(2009) H.H. Yue et al.   ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS

Monocyte Dependent Regulation of Autoimmune Inflammation

(2009) Lindsay Nicholson et al.   CURRENT MOLECULAR MEDICINE

Oral High-Dose Atorvastatin Treatment in Relapsing-Remitting Multiple Sclerosis

(2008) Friedemann Paul et al.   PLoS One

Changes in disease activity, cytokine production, and proliferation of peripheral blood mononuclear cells in patients with rheumatoid arthritis after simvastatin treatment

(2008) I. V. Shirinsky et al.   SCANDINAVIAN JOURNAL OF RHEUMATOLOGY